DAY 1 - THURSDAY MAY 28th 2020


 

8:00 am

Registration and coffee

8:45 am


Welcome Speech
Carole Guillonneau, U1064 CRTI, Nantes, France


 

SESSION I - ADVANCED CELL THERAPY

9:00 am

Reprogramming Human Immune Cells with CRISPR
Alexander Marson, University of California, San Francisco, USA

9:30 am

Overcoming barriers to efficacy for engineered T cells in solid tumors
Stanley Riddell, Fred Hutchinson Cancer Research Center, Seattle, USA

10:00 am

CAR Tregs in transplantation and autoimmunity
Ignacio Anegon, Inserm UMR 1064 - Center for Research in Transplantation and Immunology, LabEx IGO, FOCIS Center of Excellence, Nantes University

10:30 am

COFFEE BREAK

11:00 am

Human tolerogenic dendritic cells used in clinic to regulate immune responses through lactate synthesis
Aurélie Moreau, Inserm UMR 1064 - Center for Research in Transplantation and Immunology, University of Nantes / Nantes University Hospital, France

11:30 am

Selected communications


 

12:00 am

Lunch break & poster viewing session


 

SESSION II - TISSUE MICROENVIRONMENT

2:00 pm

  Immunoregulation of inflammation
  Renato Monteiro, Center for Research on Inflammation - INSERM U 1149 & CNRS ERL8252 / Paris   Diderot Faculty of Medicine

2:30 pm

Evolution of a Stromal-Immune Axis in Cancer Immunology and ImmunotherapyShannon J. Turley, Department of Cancer Immunology, Genentech, South San Francisco, CA, USA

 3:00 pm TIGIT and its cellular and bacterial ligands: new checkpoints for cancer immune therapy
Ofer Mandelboim, Institute of Medical Research Israel-Canada (IMRIC), University of Jerusalem, Israel
 

3:30 pm

COFFEE BREAK

4:00 pm

Myeloid cells and cancer immunotherapy
Antonio Sica, Dept of Pharmacological Sciences, University of Eastern Piedmont, Novara / Head lab. Molecular Immunology, Humanitas Clinical and Research Center , Milan, Italy

 4:30 pm  Immune escape mechanisms of tumors and their impact for immunotherapies
Barbara Seliger, Institute for Medical Immunology at the Martin-Luther-University Halle-Wittenberg, Germany
 

5:00 pm

Selected communications
 
 5:30 pm Cocktail & Poster viewing session
 

DAY 2 - FRIDAY MAY 29th 2020

 

8:00 am

Coffee

8:30 am


Keynote speech - New immunotherapies in cancer and autoimmunity
Jeff Bluestone, UCSF and Parker Foundation, USA


 

SESSION III - BIOREAGENTS

9:00 am

Harnessing Innate Immunity in Cancer Therapy

Eric Vivier, Aix Marseille University, APHM, CNRS, INSERM, CIML / Hôpital de la Timone, Marseille-Immunopole / Innate Pharma Research Laboratories, Marseille, France

9:30 am

IL-2-based strategies targeting Tregs to stimulate or dampen the immune response

Eliane Piaggio, Translational immunotherapy team U938, Institut Curie, Paris

10:00 am

Targeting Trained Immunity in Organ Transplantation
Jordi Ochando,
Transplant Immunology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain

10:30 am

COFFEE BREAK

11:00 am

Oncolytic activity of attenuated Measles virus and the defects in the type I interferon response in cancer

Jean-François Fonteneau, CRCINA (INSERM U1232), Nantes

11:30 am

Selected communications

 

12:00 am

LUNCH BREAK


 

SESSION IV - NEW HORIZONS

1:30 pm

Targeting common epithelial malignancies withTCR engineered lymphocytes specific for 'public' neoantigens
Christopher Klebanoff, Memorial Sloan Kettering Cancer Center and the Parker Institute for Cancer Immunotherapy, New York, USA

2:00 pm

   Genetic modifications to decrease the immunogenicity of pluripotent stem cells
   Ludovic Vallier, Cambridge Stem Cell Institute, Cambridge University, UK

2:30 pm

Analysis of immune-epithelial cell interactions by Imaging Mass Cytometry
Nicolas Damond,
Department of Quantitative Biomedicine, University of Zurich, Switzerland

3:00 pm

COFFEE BREAK

3:30 pm

Mesenchymal stromal cell heterogeneity: implication for their clinical application
Karin Tarte, Inserm U1236, University of Rennes, Rennes University Hospital, France
 

4:00 pm

Single Cell
Muzlifah Haniffa, Wellcome, Lister Institute, Newcastle Biomedical Research Centre, Institute of Cellular Medicine, Newcastle University, UK

4:30 pm

Awarding ceremony (best oral presentation, best poster)